The path to a sale is now clear - We won’t be doing any further partnering deals.
- Partnering early cost us 2/3rds of Trofinetide’s future value, but was required obviously at the time.
- We now have sufficient funds/revenue and expertise to keep progressing NNZ-2591 in multiple indications.
- Each indication keeps adding substantial future sale value.
- All of this will create huge pressure into a bidding war for our company (we didn’t have this leverage early with Arcadia)
- Maximum Value will be extracted from a sale, not dividends, buy backs or future revenue streams.
I’m happy to wait for the sale (my guess is within next 12-18months) as I’ve been here for 11 years.
Lets enjoy the “home straight”.
All my own thoughts obviously
P.s sorry I don’t post very much, but if I’m at an event that I don’t think anyone else is at I’ll contribute!!!
- Forums
- ASX - By Stock
- NEU
- The End Game Is Now Clear
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.50%
!
$20.48

The End Game Is Now Clear
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$20.48 |
Change
0.500(2.50%) |
Mkt cap ! $2.586B |
Open | High | Low | Value | Volume |
$20.10 | $20.53 | $19.95 | $14.61M | 718.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2545 | $20.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.48 | 2029 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 120 | 20.300 |
1 | 99 | 20.290 |
1 | 994 | 20.120 |
1 | 100 | 20.040 |
1 | 7242 | 20.020 |
Price($) | Vol. | No. |
---|---|---|
20.550 | 2000 | 1 |
20.600 | 183 | 5 |
20.650 | 500 | 1 |
20.670 | 145 | 1 |
20.690 | 483 | 1 |
Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online